17 April 2020
Markets continue to trade in direct correlation to novel coronavirus news.
The S&P 500 closed at 2,874 on Friday.
- The S&P 500 hit a record high of 3,393 on February 19 and bottomed at 2,191 on March 23, marking a 35% decline.
- Since then, it has rallied significantly – markets imply about 18% more to the upside (from Friday’s close) before retesting all-time highs.
- This is a remarkably bullish position given the unknowns as of Friday’s close about the virus and how to reopen without a vaccine or treatment.
- Clinical trial results are a good leading indicator of where the market is going (e.g., one we are watching closely is Gilead Sciences’ remdesivir [sic]).
- Given the persistence of COVID-19 on surfaces and its extensive incubation period, negative consequences from reopening efforts will be a lagging indicator.
- The market is looking for direction, so expect big moves based on first- and second-order COVID-19 news (e.g., government stimulus continuity and macro indicators such as unemployment, oil, and any weakness in blue chips).
- Without a treatment or vaccine intervention, resurgence risk remains a real concern for US equities.
Stay safe and play this market cautiously.
Follow me on Twitter for news as it breaks.
Disclosure: This is an opinion article not intended as investment advice – making investment decisions without your own evaluation of ideas is not investing; always do your own research and speak with an investment advisor, if you have one, before making any investment decisions. Any opinions expressed are as of the date of publication.